Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00774761 · ClinicalTrials.gov registry record · Phase 2
A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease
A Phase 2 study, sponsored by Dey.
- Completed
- Registry status
- Phase 2
- Development phase
- 97
- Enrollment target
NCT00774761 is a Phase 2 study that has completed, run by Dey. The registered enrollment target is 97 participants.
The verdict
NCT00774761, a Phase 2 study, has completed, sponsored by Dey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 97 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the systemic exposure and pharmacodynamics of two doses of nebulized fluticasone/formoterol combination as compared to the monocomponents.
Interventions
- DRUG fluticasone propionate
- DRUG fluticasone propionate/formoterol fumarate
- DRUG formoterol fumarate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00774761
The ClinicalTrials.gov registry entry for NCT00774761 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dey, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which fluticasone propionate is the first listed.
NCT00774761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00774761 about?
NCT00774761 is a clinical study titled "A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease". The purpose of this study is to evaluate the systemic exposure and pharmacodynamics of two doses of nebulized fluticasone/formoterol combination as compared to the monocomponents.
What is the current status of trial NCT00774761?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 97 participants. The study started on 2008-11. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00774761?
The interventions under investigation include: fluticasone propionate (DRUG), fluticasone propionate/formoterol fumarate (DRUG), formoterol fumarate (DRUG).
Who is sponsoring clinical trial NCT00774761?
This trial is sponsored by Dey, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.